Omnia SanaPlant Comparison
Hawthorn vs Dropwort
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Hawthorn and Dropwort: both belong to the Rosaceae family; they share 3 indicated uses (arthritis / joint pain, cancer (anticancer research), inflammation (general)); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Hawthorn | Dropwort | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 2/10 | Comparable evidence |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 2/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Principal cardioprotective and antioxidant polyphenols characterised by chemical profiling of leaf, flower and fruit.
Contribute to the vasoactive and antioxidant effects, the basis for extract standardisation.
Flavonol glycosides including spiraeoside (quercetin 4'-O-glucoside), hyperoside, rutin and kaempferol derivatives - the signature Filipendula flavonoids.
Ellagitannins and gallotannins (astringent constituents), giving the traditional astringent/antidiarrhoeal action.
Gallic, caffeic, chlorogenic and ferulic acids; antioxidant.
Catechin-based condensed tannins.
Pharmacological Actions
Antihyperalgesic in a rat inflammatory-pain model (salicylate-mediated).
Traditional use for rheumatic/arthritic pain, consistent with salicylate content and analgesic/anti-inflammatory activity.
Protective against carbon-tetrachloride liver injury in rats.
Hydrolysable-tannin astringency underlying traditional antidiarrhoeal and wound/gargle use.
Nootropic and brain-bioenergetic effects in animal models (Russian traditional nervous-system use).
Dropwort extract restrained the YAP/TAZ/TEAD oncogenic axis in mesothelioma (preclinical).
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anticancer action
inferred from anti-inflammatory action
inferred from sedative action
inferred from anticancer action
inferred from anti-rheumatic / analgesic action (salicylates)
inferred from astringent (tannin) action and traditional use
inferred from astringent/antimicrobial action and traditional wound-wash use
inferred from antimicrobial action
Nootropic (cognition-enhancing) activity in animals.
inferred from nootropic/neuroprotective action
inferred from traditional kidney/bladder 'gravel' use
inferred from traditional urinary/gravel use
Safety, Cautions & Contraindications
Generally well tolerated. Hawthorn should not replace prescribed cardiac medications without medical supervision. May potentiate the effects of cardiac glycosides (digoxin), antihypertensive drugs, and coronary dilators. Not recommended during pregnancy and breastfeeding due to insufficient safety data. Mild side effects (nausea, dizziness, GI upset) occasionally reported.
Duke (2002) rates hawthorn as +++ — one of the most clinically supported cardiovascular herbs. Clinical evidence (score 2) supports its use for decreasing cardiac output (NYHA functional Stage II heart failure), as recognized by Commission E. Key activities include vasodilation, positive inotropic effects, and antioxidant protection of vascular tissue. Dose: 160–900 mg standardized leaf/flower extract (containing 18.75% oligomeric proanthocyanidins) daily. Duke emphasizes that hawthorn should not replace conventional heart failure therapy, and therapeutic effects may take 4–8 weeks to emerge. Mild interactions with cardiac glycosides (digitalis) are possible (Duke, 2002).
Dropwort contains salicylate compounds (salicylaldehyde, methyl salicylate), as in meadowsweet and willow. Avoid in salicylate or aspirin sensitivity, and use caution alongside anticoagulant or antiplatelet medicines. As with other salicylate-containing plants, avoid in children with viral illness (theoretical Reye's syndrome risk).
Safety in pregnancy and breastfeeding has not been established; avoid medicinal doses during pregnancy and lactation.
External Ids
Botanical Description
Small deciduous tree or large shrub, densely thorny, with deeply lobed, glossy leaves (more deeply cut than midland hawthorn). Clusters of small, five-petalled white flowers with a strong, musky scent appear in spring ('May blossom'), followed by small red berries (haws), each containing a single seed (nutlet) - the origin of the species name monogyna.[4]
Erect perennial herb of the rose family, 20-80 cm tall, growing from a short rootstock whose fibrous roots bear characteristic small tuber-like swellings (the 'drop-wort' beads). The leaves are mostly in a basal rosette and are distinctive: long, fern-like and interruptedly pinnate, with many (up to 20+ pairs) small, deeply toothed leaflets. Small creamy-white flowers, often pink-tinged in bud and 6-petalled, are borne in an irregular terminal cyme. Unlike its sibling meadowsweet (Filipendula ulmaria) of wet ground, dropwort grows in dry calcareous grassland.[1, 6]
Habitat
One of the commonest hedgerow and scrub trees of Europe, growing in hedgerows, woodland edges, scrub and pasture on a wide range of soils; native to Europe, North Africa and Western Asia.[4]
Dry, unimproved calcareous (chalk and limestone) grassland, meadows, roadside banks and open scrub. Native across most of Europe, western Asia and North Africa. Unlike meadowsweet (F. ulmaria), which grows in wet meadows and beside water, dropwort is a plant of dry ground.[1]
Harvesting
Flowers are picked as they open in May, leaves are picked with the young flowering shoots, and the ripe red berries (haws) are gathered in autumn after the first frosts soften them slightly; all three parts are traditionally combined.[4]
The flowering tops and aerial parts are gathered in summer while in flower; the fern-like leaves and the small root tubers are also used. The material is dried for infusions and decoctions.[2]
Traditional Uses
Common hawthorn shares the same long cardiovascular and calming tradition as midland hawthorn, used across European herbal medicine as a heart tonic for mild circulatory complaints, palpitations and nervous tension, and remains one of the most clinically studied cardiovascular botanicals.[4]
Dropwort shares much of the European folk-medicine history of its sibling meadowsweet. The salicylate- and tannin-rich herb has been used as an astringent and anti-inflammatory remedy for diarrhoea and other gastrointestinal complaints, for rheumatic and arthritic pain, for kidney and bladder 'gravel' and urinary complaints, and as a wound and mouth wash. In Serbian and Balkan ethnomedicine the flowers and roots are used; Russian traditional medicine uses dropwort extracts as a nootropic and calming remedy for the nervous system.[2, 12, 15]
Preparations
Leaf-and-flower extract standardised to flavonoid or procyanidin content, taken as tablets or capsules; the best-studied clinical form.
Dried flowering tops or leaves infused as an astringent, anti-inflammatory tea for digestive and rheumatic complaints.
The root and root-tubers decocted; used traditionally for diarrhoea and urinary 'gravel'.
The flowers yield an aromatic oil dominated by salicylaldehyde with antimicrobial activity (as in meadowsweet).
Dosage
The EU herbal monograph on Crataegus spp., folium cum flore gives dry extracts in divided daily doses of 240-900 mg (single dose 80-450 mg) or, for one quantified extract, 570-1750 mg daily (single dose 190-350 mg), in adults and elderly. If symptoms persist longer than 2 weeks a doctor should be consulted, and hawthorn is never used as a substitute for prescribed heart medication without medical supervision. Educational reference only, not a prescription.
The EU herbal monograph gives 1-2 g of the comminuted leaf and flower in 150 mL of boiling water as an infusion, up to 4 times daily (maximum 6 g daily), in adults and elderly. Educational reference only, not a prescription.
Not documented
References
Drug Class Interactions
Lookalikes Review
Synonyms
Not documented
Pairings
Not documented
Sibling species: both are salicylate- and tannin-rich Rosaceae with overlapping anti-inflammatory, analgesic, astringent and gastroprotective uses (dropwort of dry grassland, meadowsweet of wet meadows); studied together in the same trials.[2, 3]
Both are salicylate-containing anti-inflammatory and analgesic herbs (the classic plant-aspirin group), traditionally combined for rheumatic pain and fever.[10]
Rosaceae astringents rich in hydrolysable tannins, traditionally used for diarrhoea and as gargles; studied together for antioxidant and genotoxicity profile.[16]
Dangerous Lookalikes
Not documented
References & Sources
- Ez-Zahra Amrati, F., Mssillou, I., Boukhira, S., Djiddi Bichara, M. et al (2024) 'Phenolic Composition of Crataegus monogyna Jacq. Extract and Its Anti-Inflammatory, Hepatoprotective, and Antileukemia Effects', Pharmaceuticals (Basel), 17(6), pp. 786. doi:10.3390/ph17060786 Preclinical
https://doi.org/10.3390/ph17060786 - Lis, M., Szczypka, M., Suszko-Pawłowska, A., Sokół-Łętowska, A. et al (2019) 'Hawthorn (Crataegus monogyna) Phenolic Extract Modulates Lymphocyte Subsets and Humoral Immune Response in Mice', Planta Medica, 86(2), pp. 160-168. doi:10.1055/a-1045-5437 Preclinical
https://doi.org/10.1055/a-1045-5437 - Paun, G., Neagu, E., Albu, C., Alecu, A. et al (2024) 'Antioxidant and Antidiabetic Activity of Crataegus monogyna L. and Cornus mas Fruit Extracts', Molecules, 29(15), pp. 3595. doi:10.3390/molecules29153595 Preclinical
https://doi.org/10.3390/molecules29153595 - Nabavi, S.F., Habtemariam, S., Ahmed, T., Sureda, A., Daglia, M. and Sobarzo-Sanchez, E (2015) 'Polyphenolic Composition of Crataegus monogyna Jacq.: From Chemistry to Medical Applications', Nutrients, 7(9), pp. 7708-7728. doi:10.3390/nu7095361 Meta-analysis / review
https://doi.org/10.3390/nu7095361 - Belabdelli, F., Bekhti, N., Piras, A., Benhafsa, F.M., Ilham, M. and Adil, S (2021) 'Chemical composition, antioxidant and antibacterial activity of Crataegus monogyna leaves' extracts', Natural Product Research, 36(12), pp. 3234-3239. doi:10.1080/14786419.2021.1958215 Preclinical
https://doi.org/10.1080/14786419.2021.1958215 - Jalali, A.S., Hasanzadeh, S. and Malekinejad, H (2012) 'Crataegus monogyna aqueous extract ameliorates cyclophosphamide-induced toxicity in rat testis: stereological evidences', Acta Medica Iranica, 50(1), pp. 1-8. Preclinical
https://scholar.google.com/scholar?q=Crataegus%20monogyna%20aqueous%20extract%20ameliorates%20cyclophosphamide-induced%20toxicity%20in%20rat%20testis%3A%20stereological%20evidences - Martin-Garcia, B., Razola-Diaz, M.D.C., Gomez-Caravaca, A.M., Benitez, G. and Verardo, V (2021) 'Setup of an Ultrasonic-Assisted Extraction to Obtain High Phenolic Recovery in Crataegus monogyna Leaves', Molecules, 26(15), pp. 4536. doi:10.3390/molecules26154536 Preclinical
https://doi.org/10.3390/molecules26154536 - Arslan, R., Bektas, N., Bor, Z. and Sener, E (2014) 'Evaluation of the antithrombotic effects of Crataegus monogyna and Crataegus davisii in the carrageenan-induced tail thrombosis model', Pharmaceutical Biology, 53(2), pp. 275-279. doi:10.3109/13880209.2014.914957 Preclinical
https://doi.org/10.3109/13880209.2014.914957 - Edwards, J.E., Brown, P.N., Talent, N., Dickinson, T.A. and Shipley, P.R (2012) 'A review of the chemistry of the genus Crataegus', Phytochemistry, 79, pp. 5-26. doi:10.1016/j.phytochem.2012.04.006 Meta-analysis / review
https://doi.org/10.1016/j.phytochem.2012.04.006 - Jarzycka, A., Lewinska, A., Gancarz, R. and Wilk, K.A (2013) 'Assessment of extracts of Helichrysum arenarium, Crataegus monogyna, Sambucus nigra in photoprotective UVA and UVB; photostability in cosmetic emulsions', Journal of Photochemistry and Photobiology B: Biology, 128, pp. 50-57. doi:10.1016/j.jphotobiol.2013.07.029 Preclinical
https://doi.org/10.1016/j.jphotobiol.2013.07.029 - Lucconi, G., Chlapanidas, T., Martino, E., Gaggeri, R., Perteghella, S. and Rossi, D (2013) 'Formulation of microspheres containing Crataegus monogyna Jacq. extract with free radical scavenging activity', Pharmaceutical Development and Technology, 19(1), pp. 65-72. doi:10.3109/10837450.2012.752387 Preclinical
https://doi.org/10.3109/10837450.2012.752387 - Zorniak, M., Szydlo, B. and Krzeminski, T.F (2017) 'Crataegus special extract WS 1442: up-to-date review of experimental and clinical experiences', Journal of Physiology and Pharmacology, 68(4), pp. 521-526. Meta-analysis / review
https://scholar.google.com/scholar?q=Crataegus%20special%20extract%20WS%201442%3A%20up-to-date%20review%20of%20experimental%20and%20clinical%20experiences - European Medicines Agency (2016) 'European Union herbal monograph on Crataegus spp., folium cum flore'. Traditional / reference
https://scholar.google.com/scholar?q=European%20Union%20herbal%20monograph%20on%20Crataegus%20spp.%2C%20folium%20cum%20flore - Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure'. Traditional / reference
https://scholar.google.com/scholar?q=Hawthorn%20extract%20for%20treating%20chronic%20heart%20failure - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Tankanow, R., Tamer, H.R., Streetman, D.S., Smith, S.G., Welton, J.L., Annesley, T., Aaronson, K.D. and Bleske, B.E (2003) 'Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha)', Journal of Clinical Pharmacology, 43(6), pp. 637-642. doi:10.1177/0091270003253417 Randomized trial
https://doi.org/10.1177/0091270003253417 - Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure', Cochrane Database of Systematic Reviews, 2008(1), pp. CD005312. doi:10.1002/14651858.CD005312.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD005312.pub2 - Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure', Cochrane Database of Systematic Reviews, 2008(1), pp. CD005312. doi:10.1002/14651858.CD005312.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD005312.pub2 - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003
- Katanic, J. and Pferschy-Wenzig, E. and Mihailovic, V. and Boroja, T. and Pan, S. and Nikles, S. and Kretschmer, N. and Rosic, G. and Selakovic, D. and Joksimovic, J. and Bauer, R (2018) 'Phytochemical analysis and anti-inflammatory effects of Filipendula vulgaris Moench extracts', Food and Chemical Toxicology, 122, pp. 151-162. doi:10.1016/j.fct.2018.10.001 Preclinical
https://doi.org/10.1016/j.fct.2018.10.001 - Samardzic, S. and Arsenijevic, J. and Bozic, D. and Milenkovic, M. and Tesevic, V. and Maksimovic, Z (2018) 'Antioxidant, anti-inflammatory and gastroprotective activity of Filipendula ulmaria (L.) Maxim. and Filipendula vulgaris Moench', Journal of Ethnopharmacology, 213, pp. 132-137. doi:10.1016/j.jep.2017.11.013 Preclinical
https://doi.org/10.1016/j.jep.2017.11.013 - Samardzic, S. and Tomic, M. and Pecikoza, U. and Stepanovic-Petrovic, R. and Maksimovic, Z (2016) 'Antihyperalgesic activity of Filipendula ulmaria (L.) Maxim. and Filipendula vulgaris Moench in a rat model of inflammation', Journal of Ethnopharmacology, 193, pp. 652-656. doi:10.1016/j.jep.2016.10.024 Preclinical
https://doi.org/10.1016/j.jep.2016.10.024 - Maksimovic, Z. and Petrovic, S. and Pavlovic, M. and Kovacevic, N. and Kukic, J (2007) 'Antioxidant activity of Filipendula hexapetala flowers', Fitoterapia, 78(3), pp. 265-267. doi:10.1016/j.fitote.2007.01.004 Preclinical
https://doi.org/10.1016/j.fitote.2007.01.004 - Cebovic, T. and Maksimovic, Z (2011) 'Hepatoprotective effect of Filipendula hexapetala Gilib. (Rosaceae) in carbon tetrachloride-induced hepatotoxicity in rats', Phytotherapy Research, 26(7), pp. 1088-1091. doi:10.1002/ptr.3703 Preclinical
https://doi.org/10.1002/ptr.3703 - Katanic, J. and Mihailovic, V. and Stankovic, N. and Boroja, T. and Mladenovic, M. and Solujic, S. and Stankovic, M.S. and Vrvic, M.M (2015) 'Dropwort (Filipendula hexapetala Gilib.): potential role as antioxidant and antimicrobial agent', EXCLI Journal, 14, pp. 1-20. doi:10.17179/excli2014-479 Preclinical
https://doi.org/10.17179/excli2014-479 - Matic, S. and Katanic, J. and Stanic, S. and Mladenovic, M. and Stankovic, N. and Mihailovic, V. and Boroja, T (2015) 'In vitro and in vivo assessment of the genotoxicity and antigenotoxicity of the Filipendula hexapetala and Filipendula ulmaria methanol extracts', Journal of Ethnopharmacology, 174, pp. 287-292. doi:10.1016/j.jep.2015.08.025 Preclinical
https://doi.org/10.1016/j.jep.2015.08.025 - Bousetla, A. and Erol, E. and Benarous, K. and Topcu, G. and Laouer, H. and Akkal, S. and Boulebd, H (2025) 'LC-HRESIMS-Guided Phytochemical Characterization and Bioactivity Evaluation of Filipendula hexapetala Gilib. From Algeria: Antioxidant and Anticholinesterase Potential', Chemistry and Biodiversity, 22(11), pp. e01270. doi:10.1002/cbdv.202501270 Preclinical
https://doi.org/10.1002/cbdv.202501270 - Fandakli, S. and Korkmaz, B. and Faiz, O. and Kilic, G. and Erik, I. and Terzioglu, S. and Yayli, N (2021) 'Chemical Variation, Antimicrobial, Nitric Oxide Scavenging Activities and Tyrosinase Inhibition of Essential Oils and Solvent Extracts from Filipendula vulgaris Moench Growing in Turkey', Iranian Journal of Pharmaceutical Research, 20(3), pp. 110-120. doi:10.22037/ijpr.2021.114302.14786 Preclinical
https://doi.org/10.22037/ijpr.2021.114302.14786 - Radulovic, N. and Misic, M. and Aleksic, J. and Dokovic, D. and Palic, R. and Stojanovic, G (2007) 'Antimicrobial synergism and antagonism of salicylaldehyde in Filipendula vulgaris essential oil', Fitoterapia, 78(7-8), pp. 565-570. doi:10.1016/j.fitote.2007.03.022 Preclinical
https://doi.org/10.1016/j.fitote.2007.03.022 - Pulito, C. and Korita, E. and Sacconi, A. and Valerio, M. and Casadei, L. and Lo Sardo, F. and Mori, F. and Ferraiuolo, M. and Grasso, G. and Maidecchi, A. and Lucci, J. and Sudol, M. and Muti, P. and Blandino, G. and Strano, S (2019) 'Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma', Journal of Experimental and Clinical Cancer Research, 38(1), pp. 349. doi:10.1186/s13046-019-1352-3 Preclinical
https://doi.org/10.1186/s13046-019-1352-3 - Shilova, I.V. and Suslov, N.I (2015) 'Nootropic effect of meadowsweet (Filipendula vulgaris) extracts', Bulletin of Experimental Biology and Medicine, 158(5), pp. 659-663. doi:10.1007/s10517-015-2841-9 Preclinical
https://doi.org/10.1007/s10517-015-2841-9 - Shilova, I.V. and Suslov, N.I. and Amelchenko, V.P (2015) 'Nootropic Effects of Filipendula vulgaris Moench Water Extract Fractions', Bulletin of Experimental Biology and Medicine, 159(3), pp. 376-379. doi:10.1007/s10517-015-2967-9 Preclinical
https://doi.org/10.1007/s10517-015-2967-9 - Vengerovsky, A.I. and Suslov, N.I. and Kaygorodsev, A.V (2011) 'Effect of meadowsweet (Filipendula vulgaris) extract on bioenergetics of the brain during experimental posthypoxic encephalopathy', Bulletin of Experimental Biology and Medicine, 151(4), pp. 421-424. doi:10.1007/s10517-011-1346-4 Preclinical
https://doi.org/10.1007/s10517-011-1346-4 - Vengerovskii, A.I. and Suslov, N.I. and Kaigorodtsev, A.V (2011) 'Correction of experimental anxiety behavior by meadowsweet (Filipendula vulgaris) extracts', Eksperimental'naia i Klinicheskaia Farmakologiia, 74(9), pp. 3-6. Preclinical
https://scholar.google.com/scholar?q=Correction%20of%20experimental%20anxiety%20behavior%20by%20meadowsweet%20%28Filipendula%20vulgaris%29%20extracts - Pukalskiene, M. and Slapsyte, G. and Dedonyte, V. and Lazutka, J.R. and Mierauskiene, J. and Venskutonis, P.R (2017) 'Genotoxicity and antioxidant activity of five Agrimonia and Filipendula species plant extracts evaluated by comet and micronucleus assays in human lymphocytes and Ames Salmonella/microsome test', Food and Chemical Toxicology, 113, pp. 303-313. doi:10.1016/j.fct.2017.12.031 Preclinical
https://doi.org/10.1016/j.fct.2017.12.031 - Mitchell, M.I. and Routledge, P.A (1978) 'Hemlock water dropwort poisoning - a review', Clinical Toxicology, 12(4), pp. 417-26. doi:10.3109/15563657809150012 Clinical study
https://doi.org/10.3109/15563657809150012
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.